Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer

Alessio Ugolini1, Vladimir A Tyurin2, Yulia Y Tyurina2

  • 1Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.

JCI Insight
|June 26, 2020
PubMed

Insights

Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) impair cancer immunity by blocking antigen cross-presentation in dendritic cells (DCs). Myeloperoxidase (MPO) drives this inhibition, suggesting MPO as a therapeutic target for cancer immunotherapy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Biochemistry

Background:

  • Dendritic cells (DCs) are crucial for anti-cancer immunity via antigen cross-presentation.
  • Impaired DC cross-presentation is a major hurdle for effective cancer immunotherapy.
  • Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are implicated in immune suppression within the tumor microenvironment.

Purpose of the Study:

  • To investigate the mechanism by which PMN-MDSC inhibit DC cross-presentation.
  • To identify key molecular players involved in PMN-MDSC-mediated suppression.
  • To explore the therapeutic potential of targeting PMN-MDSC in cancer immunotherapy.

Main Methods:

  • Assessing DC antigen cross-presentation in the presence of PMN-MDSC.
  • Investigating lipid transfer between PMN-MDSC and DCs.
  • Utilizing myeloperoxidase (MPO)-deficient models and pharmacological MPO inhibition.
  • Evaluating tumor progression in response to MPO inhibition combined with checkpoint blockade.

Main Results:

  • PMN-MDSC, but not neutrophils (PMN), significantly impaired DC cross-presentation without affecting direct antigen presentation.
  • This inhibition was mediated by lipid transfer from PMN-MDSC to DCs.
  • MPO activity in PMN-MDSC was essential for generating oxidized lipids that block cross-presentation.
  • MPO deficiency or pharmacological inhibition enhanced DC cross-presentation in vivo and improved anti-tumor responses when combined with checkpoint inhibitors.

Conclusions:

  • MPO-driven lipid peroxidation in PMN-MDSC represents a non-cell autonomous mechanism suppressing DC cross-presentation.
  • Targeting MPO in PMN-MDSC offers a promising strategy to overcome immune suppression and enhance cancer immunotherapy efficacy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Antigen Presenting Cells01:22

Antigen Presenting Cells

The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
2.8K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
82.9K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.9K